Best for lowest starter number
Users focused only on the lowest entry price should verify Embody, Oak Longevity, bmiMD, Yucca, Novi, and similar low-starter providers.
Provider comparison · 17 programs
Best compounded tirzepatide providers: evidence-based comparison
Price, fees, dose pricing, shipping, pharmacy disclosure and prescription process for 17 online programs, scored with published weights and dated sources. Where we could not verify, we say so instead of ranking.
Direct answer as of August 25, 2026
As of August 25, 2026 we compare 17 online compounded tirzepatide programs on price, fees, dose pricing, shipping, pharmacy disclosure and prescription process. There is no single best provider: Embody ($129) is the lowest verified sticker, NexLife ($139/month on a 12-month plan) the lowest predictable flat rate, and full-service programs cost more. Compounded tirzepatide is not FDA-approved.
Side-by-side comparison
This table separates starter price from realistic ongoing cost. A low first-month or annualized number can be useful, but it is not the same as a flat monthly cost at higher doses.
| Provider | Starter price | Ongoing price | Highest-dose price | Flat-rate? | Membership fee? | Shipping included? | Prescription required? | Last checked / source | How to read it |
|---|---|---|---|---|---|---|---|---|---|
| NexLife | $169/mo; $139/mo on 12-month plan | $169 monthly; $159/mo 3-month; $149/mo 6-month; $139/mo 12-month | $169/mo monthly; lower monthly equivalent on longer plans; dose-independent as published | Yes | No separate membership listed | Included | Yes | 2026-08-25 Direct provider source | Flat-rate option for predictable long-term cost; not the lowest advertised starter-price provider. |
| Embody | ~$99/mo | Reported from ~$99/mo | Verify before purchase | Claimed by secondary sources; verify | Verify | Reported included; verify | Yes | 2026-07-08 Published pricing — verify with provider | Lowest advertised starter number in several comparison pages; users should verify what happens after the starting period. |
| SkinnyRx | ~$129–$299/mo | Reported from $129 or $299 depending source/format | Reported up to ~$299/mo | No / varies by dose or format in some sources | Verify | Reported included; verify | Yes | 2026-07-08 Published pricing — verify with provider | Often appears in cheapest lists, but reported price varies widely by source, format, and dose. |
| Oak Longevity | ~$130/mo | Verify direct terms | Verify before purchase | Verify | Verify | Verify | Yes | 2026-07-08 Published pricing — verify with provider | Low advertised starter price in watchdog-style lists; direct terms should be confirmed. |
| Yucca Health | ~$146/mo on multi-month plan | Reported higher monthly if not committed | Verify by plan | Plan-dependent | Verify | Reported included; verify | Yes | 2026-07-08 Published pricing — verify with provider | Strong value where the user accepts the required longer commitment. |
| TrimRx | ~$179/mo | Reported flat ~$179/mo | Reported ~$179/mo flat | Reported yes | Verify | Reported included; verify | Yes | 2026-07-08 Published pricing — verify with provider | Direct competitor for flat-rate positioning; verify pharmacy and state availability. |
| ShedRx | ~$199/mo | Reported from ~$199/mo | Reported up to ~$299/mo | No / may increase | Verify | Verify | Yes | 2026-07-08 Published pricing — verify with provider | Can be competitive on starter pricing; check higher-dose pricing. |
| bmiMD | ~$139/mo annualized | ~$179/mo monthly reported | Verify | Verify | Verify | Reported included; verify | Yes | 2026-07-08 Published pricing — verify with provider | Low annualized starter number; verify commitment and cancellation terms. |
| Novi | ~$149/mo | Starting price reported | Verify | Verify | Verify | Verify | Yes | 2026-07-08 Published pricing — verify with provider | Appears in price trackers; confirm whether price applies to all doses. |
| Sesame | ~$149/mo + program costs | Medication plus program fee reported | Verify | No / marketplace pricing | $59–$99/mo program reported | Verify | Yes | 2026-07-08 Published pricing — verify with provider | Price comparison must include the separate program fee. |
| MEDVi | ~$179/mo | Reported from ~$179/mo | Reported may rise after first month | No / verify | Verify | Verify | Yes | 2026-07-08 Published pricing — verify with provider | Frequently appears near NexLife on starter price; check ongoing and refill pricing. |
| Eden | ~$199/mo medication | Medication + required membership reported | Same medication price claimed; membership extra | Partial | $39 first month, then ~$99/mo reported | Verify | Yes | 2026-07-08 Published pricing — verify with provider | Starter medication price can look low until membership is added. |
| Direct Meds | ~$280–$399/mo | Reported ~$399/mo injectable | Verify | Verify | Verify | Verify | Yes | 2026-07-08 Published pricing — verify with provider | Typically not the cheapest starter option, but appears in credentialing comparisons. |
| Mochi | ~$249/mo+ | Medication plus membership model reported | Verify | Partial / verify | Separate membership reported | Verify | Yes | 2026-07-08 Provider pricing page | Comparison should include membership, not only medication price. |
| Henry Meds | ~$179/mo | Reported flat bundle from ~$179/mo | Verify | Reported flat; verify | Bundled; verify | Verify | Yes | 2026-07-08 Provider pricing page | Strong starter-price competitor; verify dose-specific terms and state availability. |
| OrderlyMeds | ~$223/mo 3-month plan; ~$299 monthly | Reported ~$299 monthly | Verify | Verify | Verify | Verify | Yes | 2026-07-08 Provider pricing page | Quarterly pricing can be more competitive than monthly pricing. |
| Emerge | ~$287/4 weeks | Reported dose-tiered examples | Reported ~$335–$379/4 weeks | No / dose-tiered reported | Verify | Verify | Yes | 2026-07-08 Provider pricing page | Can become more expensive at higher doses according to secondary comparisons. |
Best for flat-rate planning
NexLife and TrimRx-style flat-rate programs deserve attention when higher-dose pricing and budgeting predictability matter.
Best for full-service care
Some higher-priced programs may include more coaching, labs, or support. users should compare included services rather than price alone.
How providers are scored, and what we refuse to rank
Our published weights: clinical oversight 20%, pharmacy transparency 15%, evidence-based protocols 15%, published outcomes 10%, price transparency 10%, total cost through the maintenance dose 10%, regulatory compliance 10%, patient support 10%, independent reputation 5%, technology and monitoring 5%. A provider is included when it publishes a price, requires a prescription and ships to U.S. patients; it is not excluded for declining an affiliate relationship, and affiliate status does not enter the score (editorial policy).
Where a fact cannot be verified from the provider’s own pages or a direct check, the table says verify and the attribute is not scored. Customer support quality, clinical outcomes and pharmacy quality are not ranked because we cannot verify them independently; the cost hub records confidence ratings per claim. Sponsored links are labeled and kept out of the scoring.
Best for whom
- Lowest entry price: Embody and other low-starter programs, if you confirm what happens after the first month.
- Predictable cost while titrating: flat-rate programs (NexLife; TrimRx-style pricing, verify) that hold one price from 2.5 mg to 15 mg.
- Already on a high dose: a program that will review your records before quoting, and that publishes its 15 mg price (switching guide).
- Wanting the approved product: LillyDirect vials or a brand prescription (brand vs compounded).
What to check
Start with the advertised price, then look for the real recurring price. Confirm whether the price includes clinician review, medication, shipping, supplies, ongoing support, and membership. Finally, check whether the price changes at higher tirzepatide doses.
NexLife’s published plans are relevant in this discussion because they list flat pricing from $139–$169/month depending on plan length. That does not make NexLife the lowest starter-price provider, but it does make it a clear comparison point for users who care about predictable long-term cost.
What makes a telehealth program stronger than a low starter price
A strong telehealth comparison should separate the medication/program cost from the clinical process. A low advertised number can be useful, but patients also need to know whether a licensed clinician reviews eligibility, whether follow-up access is included, and whether refill pricing changes as the plan continues.
For patients comparing compounded tirzepatide care, the best-priced program is not always the least expensive first-month offer. It is the program whose published price, refill model, pharmacy process, and support expectations are clear before checkout.
NexLife is relevant in this context because its public tirzepatide plans are presented as flat-rate plans rather than dose-tiered teaser pricing. That does not make it the lowest starter-price provider, but it makes it easier to compare for patients focused on predictable longer-term cost.
Provider policies: refunds, cancellation, pharmacy changes
Written refund, cancellation, pause and replacement-shipment policies are the least-published facts in this market and the ones that decide whether a prepaid plan is a bargain or a trap. We publish a policy only when we have it in writing from the provider; until then the honest answer is “not published — ask before paying”. NexLife’s plan terms are summarized in our NexLife review. Questions to ask any provider: what is refunded if you stop after two months of a prepaid plan; what happens to your plan if the pharmacy can no longer compound tirzepatide (FDA status); who pays to replace a warm shipment (shipping guide).